Open AccessEfficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children
Author(s) -
Tristan Bourcier,
Anne Dory,
Léa Dormegny,
Joffrey Alcazar,
David Gaucher,
Arnaud Sauer
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s370414
Subject(s) - medicine , vernal keratoconjunctivitis , corticosteroid , cohort , dose , population , clinical trial , pediatrics , dermatology , surgery , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom